Brief: Bausch Health Provides Update On RED-C Phase 3 Clinical Trials
23/01/2026 12:48
Jan 23 (Reuters) - Bausch Health Companies Inc BHC.TO: BAUSCH HEALTH PROVIDES UPDATE ON RED-C PHASE 3 CLINICAL TRIALS BAUSCH HEALTH COMPANIES INC - PHASE 3 TRIALS DID NOT MEET PRIMARY ENDPOINT Source text: ID:nCNWFGCR8a Further company coverage: BHC.TO ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bausch Health Companies
See all newsCanada Stocks: TSX inches lower as tech and mining shares fall
Bausch Health Companies Inc. reports results for the quarter ended September 30 - Earnings Summary
Brief: Bausch Health Announces Full Redemption Of 8.500% Senior Notes Due 2027
Brief: Bausch Health Announces $50 Million Share Repurchase Program
Brief: Bausch Health Announces $50 Million Share Repurchase Program